Remdesivir was given to this patient, with no benefit observed. Based on other studies, remdesivir, sadly, seems to be a dud.

For this same patient, Leronlimab was considered, but the doctor stated that he had obtained approval to give Leronlimab to one of his patients, who probably would have survived the coronavirus anyway, and is going to survive, but the patient had a bad reaction and suffered irreversible side effect damage such that he will be disabled for life. So Leronlimab is not the panacea people are hoping for.